Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorambucil vs Observation After Anti-Helicobacter Therapy in Low Grade Gastric Lymphoma
NCT00003617Phase 3Unknown
- Sponsor
- Lymphoma Trials Office
- Start
- Mar 1995
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in gastric lymphoma comparing Chlorambucil with Placebo (2 arms). Primary endpoints: Response Rate of Triple Antibiotic Therapy and Relapse Rate up to 2 years. Status: unknown.
02
Drugs
chlorambucil
03
Conditions
gastric lymphoma
Beyond the preview
Go deeper on NCT00003617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003617.